Similarly, we found that MEG8, NAV2-AS2, STEAP3-AS1, GLIS3-AS1 and AC012640.1 were expressed at high levels and LINC00158 was expressed at low levels in recurrent BC patients. This evidence concerns the gene NAV2 and breast cancer.